(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic injuries or who require ...
Robert Linhardt is working to forever change the way some of the most widely used drugs in the world are manufactured. Today, in the journal Science, he and his partner in the research, Jian Liu, have announced an important ...
Oct 27, 2011
0
0
Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight ...
Jan 4, 2023
0
4
Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower the risk of ...
Nov 7, 2022
0
4
An international team of scientists has discovered a molecule that prevents tumor cells spreading from a primary cancer site to colonize other sites in the body.
Jul 25, 2022
0
55
A large-scale study is the first to evaluate blood viscosity in the prediction of mortality in COVID-19 patients. A simple calculation of blood viscosity was more robust in the identification of hospitalized patients at risk ...
Jul 18, 2022
0
12
A research team led by Prof. Dr. Tamam Bakchoul from the Institute for Clinical and Experimental Transfusion Medicine (IKET) at the University Hospital of Tübingen is investigating the suitability of anticoagulants in patients ...
Jun 23, 2022
0
2
Heparin, a widely available and affordable drug, has found to limit lung damage when inhaled by COVID-19 patients.
Jan 21, 2022
0
29
An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the University of Melbourne and Monash University receive $4.2 million to establish a six-month clinical trial ...
Dec 28, 2021
1
40
A high dose of an inexpensive and globally available blood-thinning medication reduces the risk of death in hospitalized patients who are moderately ill with COVID-19, suggests a new study led by St. Michael's Hospital.
Oct 15, 2021
0
143
